THERAVANCE BIOPHARMA INC shareholder history

Current and past THERAVANCE BIOPHARMA INC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
Context Capital Management, LLC 23230.66%2.54%4.70%Q4 2016Q2 202223
Rock Springs Capital Management LP 23230.03%0.06%0.12%Q4 2016Q2 202223
Baupost Group 23230.23%0.32%0.46%Q4 2016Q2 202223
WOLVERINE ASSET MANAGEMENT LLC 19190.01%0.28%0.41%Q4 2016Q2 202119
SSI INVESTMENT MANAGEMENT LLC 19190.09%0.21%0.36%Q4 2016Q2 202119
GABELLI FUNDS LLC 19190.01%0.02%0.03%Q4 2016Q2 202119
ZAZOVE ASSOCIATES LLC 1720.05%0.93%2.00%Q3 2017Q2 202219
Citadel Advisors 19190.01%0.02%0.03%Q4 2016Q2 202119
Verition Fund Management LLC 1610.04%0.37%1.25%Q4 2016Q1 202218
WELLS FARGO & COMPANY/MN 18180.00%0.00%0.00%Q1 2018Q2 202218
MORGAN STANLEY 18180.00%0.00%0.00%Q2 2017Q3 202118
FMR LLC 17170.00%0.00%0.00%Q4 2016Q4 202017
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 16160.00%0.00%0.00%Q3 2018Q2 202216
Castle Creek Arbitrage, LLC 15150.06%0.87%2.59%Q4 2017Q2 202115
Mohican Financial Management, LLC 15150.63%1.58%2.40%Q4 2016Q2 202015
LINDEN ADVISORS LP 14140.05%1.73%3.79%Q4 2016Q1 202014
TENOR CAPITAL MANAGEMENT Co., L.P. 1030.10%0.26%0.99%Q4 2016Q2 202213
DeepCurrents Investment Group LLC 840.22%1.07%2.73%Q4 2018Q2 202212
Bank of New York Mellon Corp 11110.00%0.00%0.00%Q3 2019Q1 202211
BARCLAYS PLC 650.00%0.00%0.00%Q1 2019Q4 202111
CSS LLC/IL 640.08%0.32%1.06%Q4 2016Q1 202010
Calamos Advisors LLC 10100.01%0.03%0.04%Q2 2018Q3 202010
GABELLI & Co INVESTMENT ADVISERS, INC. 990.04%0.07%0.13%Q2 2019Q2 20219
CENTRAL TRUST Co 880.01%0.01%0.01%Q3 2018Q2 20208
HIGHBRIDGE CAPITAL MANAGEMENT LLC 620.43%0.74%1.22%Q4 2016Q2 20228
Aequim Alternative Investments LP 770.20%0.37%0.50%Q4 2020Q2 20227
LAZARD ASSET MANAGEMENT LLC 520.01%0.02%0.03%Q2 2017Q2 20207
PALISADE CAPITAL MANAGEMENT, LP 660.00%0.02%0.03%Q1 2021Q2 20226
AVIVA PLC 420.01%0.05%0.07%Q1 2017Q2 20226
JPMORGAN CHASE & CO 510.00%0.00%0.00%Q2 2017Q1 20206
FARALLON CAPITAL MANAGEMENT LLC 660.14%0.27%0.34%Q1 2020Q2 20216
GEODE CAPITAL MANAGEMENT, LLC 550.00%0.00%0.00%Q2 2017Q2 20185
OAKTREE CAPITAL MANAGEMENT LP 320.07%0.08%0.09%Q1 2021Q2 20225
Parallax Volatility Advisers, L.P. 440.00%0.06%0.24%Q3 2021Q2 20224
CAPSTONE INVESTMENT ADVISORS, LLC 310.01%0.02%0.05%Q1 2020Q2 20214
Kohlberg Kravis Roberts & Co. L.P. 440.00%0.12%0.22%Q2 2019Q1 20204
Russell Investments Group, Ltd. 310.00%0.00%0.00%Q2 2021Q2 20224
CITIGROUP INC 220.00%0.00%0.00%Q4 2017Q3 20194
BANK OF AMERICA CORP /DE/ 210.00%0.00%0.00%Q3 2017Q4 20214
DEUTSCHE BANK AG\ 210.00%0.00%0.00%Q2 2017Q2 20204
HBK INVESTMENTS L P 440.08%0.15%0.25%Q3 2021Q2 20224
Maven Securities LTD 330.42%0.47%0.52%Q3 2021Q1 20223
Saltoro Capital, LP 330.24%0.34%0.44%Q3 2021Q1 20223
Shaolin Capital Management LLC 220.30%0.62%0.93%Q4 2020Q1 20212
UBS Group AG 220.00%0.00%0.00%Q4 2016Q1 20172
BlueCrest Capital Management Ltd 220.24%0.41%0.58%Q4 2016Q1 20172
Weiss Asset Management LP 220.50%0.51%0.52%Q4 2016Q1 20172
EcoR1 Capital, LLC 225.42%5.79%6.15%Q4 2016Q1 20172
BNP PARIBAS FINANCIAL MARKETS 220.00%0.00%0.01%Q1 2020Q2 20202
ADVENT CAPITAL MANAGEMENT /DE/ 220.08%0.09%0.10%Q2 2018Q3 20182
Context Partners Fund, L.P. 111.38%2.93%4.48%Q3 2018Q3 20202
TFG Asset Management GP Ltd 110.57%0.57%0.57%Q4 2016Q4 20161
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 110.22%0.22%0.22%Q4 2016Q4 20161
Opera Trading Capital 110.27%0.27%0.27%Q2 2017Q2 20171
BALYASNY ASSET MANAGEMENT L.P. 110.02%0.02%0.02%Q3 2021Q3 20211
WELLINGTON MANAGEMENT GROUP LLP 110.00%0.00%0.00%Q3 2020Q3 20201
AGF INVESTMENTS INC. 110.02%0.02%0.02%Q2 2020Q2 20201
Opti Capital Management, LP 110.20%0.20%0.20%Q2 2019Q2 20191
BASSO CAPITAL MANAGEMENT, L.P. 110.45%0.45%0.45%Q2 2017Q2 20171
PRELUDE CAPITAL MANAGEMENT, LLC 110.00%0.00%0.00%Q3 2021Q3 20211

This page lists all the filers that currently own THERAVANCE BIOPHARMA INC or have owned THERAVANCE BIOPHARMA INC in the past.